Mohammad A Y Alqudah Selected Research

Mohammad A Y Alqudah Research Topics

Disease

9	Neoplasms (Cancer) 01/2024 - 01/2013
3	Glioma (Gliomas) 01/2013 - 03/2012
2	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 11/2022
2	Breast Neoplasms (Breast Cancer) 06/2022 - 03/2022
2	Hypoglycemia (Reactive Hypoglycemia) 10/2019 - 01/2019
1	Multiple Myeloma 01/2024
1	Erectile Dysfunction 01/2024
1	Mpox (monkeypox) 04/2023
1	Smallpox (Variola) 04/2023
1	Brain Neoplasms (Brain Tumor) 11/2022
1	Neoplasm Metastasis (Metastasis) 03/2022
1	Wounds and Injuries (Trauma) 03/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 07/2018
1	Hypertension (High Blood Pressure) 07/2018
1	Memory Disorders (Memory Loss) 03/2018
1	Prostatic Neoplasms (Prostate Cancer) 02/2018
1	Hyperlipidemias (Hyperlipidemia) 02/2018
1	Rheumatoid Arthritis 08/2017
1	Ulcer 08/2016
1	Common Cold 05/2016
1	Headache (Headaches) 05/2016

Drug/Important Bio-Agent (IBA)

2	Proton Pump InhibitorsIBA 01/2024 - 08/2016
2	EnzymesIBA 01/2023 - 12/2022
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 11/2022
2	Insulin (Novolin)FDA Link 10/2019 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 07/2018 - 03/2012
1	Sildenafil Citrate (Viagra)FDA Link 01/2024
1	Phosphodiesterase 5 InhibitorsIBA 01/2024
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2024
1	Antiviral Agents (Antivirals)IBA 04/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Biomarkers (Surrogate Marker)IBA 11/2022
1	Etoposide (VP 16)FDA LinkGeneric 11/2022
1	1,4-dihydropyridine (dihydropyridine)IBA 06/2022
1	Calcium Channels (Calcium Channel)IBA 06/2022
1	CaspasesIBA 06/2022
1	Antineoplastic Agents (Antineoplastics)IBA 06/2022
1	Amlodipine (Norvasc)FDA LinkGeneric 06/2022
1	Chemotactic FactorsIBA 03/2022
1	matrigelIBA 03/2022
1	CalciumIBA 03/2022
1	IntegrinsIBA 03/2022
1	Calcium-Sensing ReceptorsIBA 03/2022
1	Caspase 3 (Caspase-3)IBA 03/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2019
1	Hormones (Hormone)IBA 01/2019
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 07/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2018
1	Interleukin-6 (Interleukin 6)IBA 07/2018
1	AntioxidantsIBA 03/2018
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 02/2018
1	Simvastatin (Zocor)FDA LinkGeneric 02/2018
1	Antirheumatic Agents (DMARD)IBA 08/2017
1	Protein Tyrosine PhosphatasesIBA 01/2013
1	Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA 01/2013
1	Temozolomide (Temodar)FDA LinkGeneric 01/2013
1	Tyrosine Kinase InhibitorsIBA 01/2013
1	CateninsIBA 01/2013
1	Notch ReceptorsIBA 01/2013
1	Tyrosine (L-Tyrosine)FDA Link 01/2013

Therapy/Procedure

6	Therapeutics 01/2024 - 01/2013
2	Drug Therapy (Chemotherapy) 01/2013 - 01/2013
1	Traction 12/2022
1	Self Medication 05/2016